HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Angiomyolipoma with Epithelial Cysts (AMLEC) of the Kidney].

Abstract
A 49-year-old man was demonstrated to have two tumors in the right kidney by computed tomographic scan during an examination for cholelithiasis. One was a fat rich solid tumor which was clinically diagnosed as angiomyolipoma, and the other was an unconfirmed cystic tumor. Cholecystectomy and radical nephrectomy were performed. Based on pathological findings, the solid tumor was diagnosed as common angiomyolipoma and the cystic tumor as angiomyolipoma with epithelial cysts (AMLEC). The cystic tumor consisted of 3 components : an epithelial cyst lined with single flat to cuboidal cells, a subepithelial compact stroma and an external layer of muscle predominant angiomyolipoma. Immunohistochemical examinations showed strong intense staining of pan-cytokeratin in the epithelium lining the cyst. The subepithelial compact stroma was stained with both CD10 and HMB45. The muscle predominant angiomyolipoma exhibited expression of HMB45. AMLEC is a recently recognized rare variant of angiomyolipoma.
AuthorsKazushiro Takei, Shinichi Shimizu, Yoshiro Otsuki
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 62 Issue 7 Pg. 355-60 (Jul 2016) ISSN: 0018-1994 [Print] Japan
PMID27569353 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Biomarkers, Tumor
  • Melanoma-Specific Antigens
  • PMEL protein, human
  • gp100 Melanoma Antigen
  • Keratins
  • Neprilysin
Topics
  • Angiomyolipoma (complications, diagnosis, pathology, surgery)
  • Biomarkers, Tumor (analysis)
  • Cholecystectomy
  • Humans
  • Immunohistochemistry
  • Keratins (analysis)
  • Kidney Diseases, Cystic (complications, diagnosis, pathology, surgery)
  • Male
  • Melanoma-Specific Antigens (analysis)
  • Middle Aged
  • Nephrectomy
  • Neprilysin (analysis)
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • gp100 Melanoma Antigen

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: